Provided by Tiger Fintech (Singapore) Pte. Ltd.

Denali Therapeutics Inc.

14.80
+0.43002.99%
Post-market: 14.51-0.2900-1.96%16:08 EDT
Volume:1.51M
Turnover:22.65M
Market Cap:2.15B
PE:-5.54
High:15.56
Open:15.29
Low:14.64
Close:14.37
Loading ...
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors